Flow cytometric analysis of peripheral blood and bone marrow for tumor cells in patients with neuroblastoma

Cancer

Volumn 82, Issue 3, 1998, Pages 591-599

  Komada, Yoshihiro ^a   Zhang, Xao Li ^a   Zhou, Yan Wen ^a   Inaba, Hiroto ^a   Deguchi, Takao ^a   Azuma, Eiichi ^a   Sakurai, Minoru ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Cell surface antigens; Flow cytometry; Fluorescence activated cell sorting; N myc amplification; Neuroblastoma; Polymerase chain reaction; Tumor contamination

Indexed keywords

CD45 ANTIGEN; CD56 ANTIGEN; CD9 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BLOOD; BONE MARROW; CANCER CELL; CELL SELECTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; NEUROBLASTOMA; ONCOGENE C MYB; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL;

ANTIGENS, CD; ANTIGENS, CD45; ANTIGENS, CD56; BONE MARROW CELLS; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; GENES, MYC; HUMANS; IMMUNOPHENOTYPING; INFANT; MALE; MEMBRANE GLYCOPROTEINS; NEOPLASM CIRCULATING CELLS; NEUROBLASTOMA; POLYMERASE CHAIN REACTION;

EID: 0032007329     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980201)82:3<591::AID-CNCR23>3.0.CO;2-W     Document Type: Article

References (35)

1. Brodeur GM, Castleberry RP. Neuroblastoma. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 2nd ed. Philadelphia: JB Lippincott, 1993:739-67.
2. Taylor SR, Locker J. A comparative analysis nuclear DNA content and N-myc gene amplification in neuroblastoma. Cancer 1990;65:1360-6.
3. Garvin J, Bendit I, Nisen PD. N-myc oncogene expression and amplification in metastatic lesions of stage IV-S neuroblastoma. Cancer 1990;65:2572-5.
4. Ladenstein R, Lasset C, Hartmann O, Klingebiel T, Bouffet E, Gadner H, et al. Comparison of auto vs. allografting as consolidation of primary treatments in advanced neuroblastoma over 1 year of age at diagnosis: report from the European Group of Bone Marrow Transplantation. Bone Marrow Transplant 1994;14:37-46.
5. Kushner BH, O'Reilly RJ, Mandell LR, Gulati SC, LaQuaglia M, Cheung NV. Myeloablative combination chemotherapy without total body irradiation for neuroblastoma. J Clin Oncol 1991;9:274-9.
6. Stram DO, Matthay KK, O'Leary M, Reynolds CP, Haase GM, Atkinson JB, et al. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Study Group studies. J Clin Oncol 1996;14:2417-26.
7. D2 specific monoclonal antibodies. J Clin Oncol 1986;4:363-9.
8. Favrot MC, Frappaz D, Maritaz O, Philip I, Fontaniere B, Gentilhomme O, et al. Histological, cytological and immunological analyses are compensatory for the detection of neuroblastoma cells in bone marrow. Br J Cancer 1986;54:637-41.
9. Rogers DW, Treleaven JG, Kemshead JT, Pritchard J. Monoclonal antibodies for detecting bone marrow invasion by neuroblastoma. J Clin Pathol 1989;42:422-6.
10. Moss TJ, Sanders DG. Detection of neuroblastoma cells in blood. J Clin Oncol 1990;8:736-40.
11. Moss TJ, Reynolds CP, Sather HN, Romansky SG, Hammond GD, Seeger RC. Prognostic value of immunologic detection of bone marrow metastases in neuroblastoma. N Engl J Med 1991;324:219-26.
12. Saarinen UM, Wikstrom S, Makipernaa A, Lanning M, Perkkio M, Hovi L, et al. In vivo purging of bone marrow in children with poor-risk neuroblastoma for marrow collection and autologous bone marrow transplantation. J Clin Oncol 1996;14:2791-802.
13. Naito H, Kuzumaki N, Uchino J, Kobayashi R, Shikano T, Ishikawa Y, et al. Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Eur J Cancer 1991;27:762-5.
14. Miyajima Y, Kato K, Numata S, Kudo K, Horibe K. Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA. Cancer 1995;75:2757-61.
15. Mattano LA, Moss TJ, Emerson SG. Sensitive detection of rare neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res 1992;52:4701-5.
16. Evans AE, D'Angio GS, Randolph J. A proposed staging for children with neuroblastoma: Children's Cancer Study Group A. Cancer 1971;27:374-8.
17. Gilbert J, Norris MD, Haber M, Kavallaris M, Marshall GM, Stewart BW. Determination of N-myc gene amplification in neuroblastoma by differential polymerase chain reaction. Mol Cell Probes 1993;7:227-34.
18. Kemshead JT, Fritschy J, Garson JA, Allan P, Coakham H, Brown S, et al. Monoclonal antibody UJ 127:11 detects a 220,000-240,000 dalton glycoprotein present on a sub-set of neuroectodermally derived cells. Int J Cancer 1983;31:187-95.
19. Kemshead JT, Goldman A, Fritschy J, Malpas JS, Pritchard J. Use of panels of monoclonal antibodies in the differential diagnosis of neuroblastoma and lymphoblastic disorders. Lancet 1983;1:12-5.
20. Sugimoto T, Tatsumi E, Kemshead JT, Helson L, Green AA, Minowada J. Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies. J Natl Cancer Inst 1984;73:51-7.
21. Cheung NV, Saarinen UM, Neely JE, Landmeier B, Donovan D, Coccia PF. Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells. Cancer Res 1985;45:2642-9.
22. Smith RG, Reynolds CP. Monoclonal antibody recognizing a human neuroblastoma-associated antigen. Diag Clin Immunol 1987;5:209-20.
23. Moss TJ, Rosenblatt HM, Seeger RC. Expression of a developmental stage-specific antigen by neuronal precursor cells of human fetal cerebellum. J Neuroimmunol 1988;20:3-14.
24. Mechterheimer G, Barth T, Ludwig R, Staudter M, Med C, Moller P. Differential expression of leukocyte differential antigens in small round blue cell sarcomas. Cancer 1993;71:237-48.
25. Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, et al. Leucocyte typing V: white cell differentiation antigens. Tokyo: Oxford University Press, 1993.
26. Komada Y, Peiper SC, Melvin SL, Metzger DW, Tarnowski BH, Green AA. A monoclonal antibody (SJ-9A4) to p24 present on common ALLs, neuroblastomas and platelets: I. characterization and development of a unique radioimmunometric assay. Leuk Res 1983;7:487-98.
27. Komada Y, Azuma E, Kamiya H, Sakurai M. Phenotypic profile of human neuroblastoma cell lines: association with morphological characteristics. Br J Cancer 1986;54:711-5.
28. Lanier LL, Testi R, Bindl R, Phillips JH. Identity of Leu-19 (CD56) leucocyte differentiation antigen and neural cell adhesion molecule. J Exp Med 1989;169:2233-8.
29. Pollerberg ED, Sadoul R, Goridis C, Schachner M. Selective expression of the 180 kDa component of the neural cell adhesion molecule N-CAM during development. J Cell Biol 1985;101:1921-9.
30. Lipinski M, Hirsch M-R, Deagistini-Bazin H, Yamada O, Tursz T, Goridis C. Characterization of neural cell adhesion molecules (NCAM) expressed by Ewing and neuroblastoma cell lines. Int J Cancer 1987;40:81-6.
31. Donner L, Triche TJ, Israel MA, Seeger RC, Reynolds CP. A panel of monoclonal antibodies which discriminate neuroblastoma from Ewing's sarcoma, rhabdomyosarcoma, neuroepithelioma, and hematopoietic malignancies. In: Evans AE, D'Angio G, Seeger RC, editors. Advance in neuroblastoma research. New York: Alan R. Liss, 1985:347-66.
32. Oppedal BR, Storm-Mathisen I, Kemsheat JT, Brandzaeg P. Bone marrow examination in neuroblastoma patients: a morphologic, immunocytochemical, and immunohistochemical study. Hum Pathol 1989;20:800-5.
33. Sanders DG, Wiley FM, Moss TJ. Serial immunologic analysis of blood for tumor cells in two patients with neuroblastoma. Cancer 1991;57:1423-7.
34. Miyajima Y, Horibe K, Fukuda M, Matsumoto K, Numata S, Mori H, et al. Sequential detection of tumor cells in the peripheral blood and bone marrow of patients with stage IV neuroblastoma by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA. Cancer 1996;77:1214-9.
35. Moss TJ, Sanders DG, Lasky LC, Bostrom B. Contamination of peripheral blood stem cell harvests by circulating neuroblastoma cells. Blood 1990;76:1879-83.